Stockreport

Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029 [Yahoo! Finance]

Lifecore Biomedical, Inc.  (LFCR) 
PDF completed its transition into a “standalone CDMO” after divesting its former food businesses in 2022 and 2023. Josephs said Lifecore is now focused on two primary operat [Read more]